DNAPrint Genomics Financials
Based on the key indicators related to DNAPrint Genomics' liquidity, profitability, solvency, and operating efficiency, DNAPrint Genomics may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter. At this time, DNAPrint Genomics' Accounts Payable is most likely to increase significantly in the upcoming years. The DNAPrint Genomics' current Total Liabilities is estimated to increase to about 16.9 M, while Total Stockholder Equity is forecasted to increase to (3.2 M).
At this time, DNAPrint Genomics' Accounts Payable is most likely to increase significantly in the upcoming years. The DNAPrint Genomics' current Total Liabilities is estimated to increase to about 16.9 M, while Total Stockholder Equity is forecasted to increase to (3.2 M). Key indicators impacting DNAPrint Genomics' financial strength include:
DNAPrint Genomics Balance Sheet Chart
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.34 | 0.57 |
|
|
Investors should never underestimate DNAPrint Genomics' ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to research DNAPrint Genomics' cash flow, debt, and profitability to make informed and accurate decisions about investing in DNAPrint Genomics.
Net Income |
|
DNAPrint | Select Account or Indicator | Build AI portfolio with DNAPrint Stock |
Understanding current and past DNAPrint Genomics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of DNAPrint Genomics' financial statements are interrelated, with each one affecting the others. For example, an increase in DNAPrint Genomics' assets may result in an increase in income on the income statement.
DNAPrint Genomics Stock Summary
DNAPrint Genomics, Inc. engages in the development and marketing of genetic testing products and services. The company was incorporated in 1983 and is based in Sarasota, Florida with a subsidiary in Leverkusen, Germany. DNAPRINT GENOMICS is traded on OTC Exchange in the United States.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | OTCCE Exchange |
| ISIN | US23324Q1031 |
| Business Address | 1621 West University |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Phone | 941 366 3400 |
| Currency | USD - US Dollar |
DNAPrint Genomics Key Financial Ratios
| Profit Margin | (2.36) % | ||||
| Operating Margin | (7.31) % | ||||
| Price To Sales | 0.20 X | ||||
| Revenue | 2.43 M | ||||
| Gross Profit | 446.37 K |
DNAPrint Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining DNAPrint Genomics's current stock value. Our valuation model uses many indicators to compare DNAPrint Genomics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across DNAPrint Genomics competition to find correlations between indicators driving DNAPrint Genomics's intrinsic value. More Info.DNAPrint Genomics is rated # 2 in return on asset category among its peers. It is one of the top stocks in profit margin category among its peers . At this time, DNAPrint Genomics' Net Loss is most likely to increase significantly in the upcoming years. Comparative valuation analysis is a catch-all technique that is used if you cannot value DNAPrint Genomics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Most indicators from DNAPrint Genomics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into DNAPrint Genomics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DNAPrint Genomics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more detail on how to invest in DNAPrint Stock please use our How to Invest in DNAPrint Genomics guide.The DNAPrint Genomics' current Enterprise Value is estimated to increase to about 14.8 M, while Selling General Administrative is projected to decrease to roughly 2.8 M.
| 2010 | 2011 | 2025 | 2026 (projected) | Gross Profit | 29K | 754.1K | 867.2K | 910.5K | Total Revenue | 33K | 2.4M | 2.8M | 2.9M |
DNAPrint Genomics fundamental ratios Correlations
Click cells to compare fundamentals
DNAPrint Genomics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
About DNAPrint Genomics Financials
What exactly are DNAPrint Genomics Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include DNAPrint Genomics' income statement, its balance sheet, and the statement of cash flows. Potential DNAPrint Genomics investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although DNAPrint Genomics investors may use each financial statement separately, they are all related. The changes in DNAPrint Genomics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on DNAPrint Genomics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Today, most investors in DNAPrint Genomics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various DNAPrint Genomics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of DNAPrint Genomics growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Complementary Tools for DNAPrint Stock analysis
When running DNAPrint Genomics' price analysis, check to measure DNAPrint Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DNAPrint Genomics is operating at the current time. Most of DNAPrint Genomics' value examination focuses on studying past and present price action to predict the probability of DNAPrint Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DNAPrint Genomics' price. Additionally, you may evaluate how the addition of DNAPrint Genomics to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Stocks Directory Find actively traded stocks across global markets |